Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 2
1978 1
1979 1
1980 2
1984 1
1985 2
1986 1
1991 1
1993 1
1998 3
1999 1
2001 3
2002 3
2003 3
2004 1
2005 3
2006 3
2007 3
2008 4
2009 1
2010 3
2011 12
2012 8
2013 6
2014 5
2015 5
2016 2
2017 3
2018 6
2019 11
2020 5
2021 9
2022 10
2023 5
2024 9
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.
Pirnay JP, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, Glonti T, Spiessens A, Vanden Berghe E, Green S, Wagemans J, Lood C, Schrevens E, Chanishvili N, Kutateladze M, de Jode M, Ceyssens PJ, Draye JP, Verbeken G, De Vos D, Rose T, Onsea J, Van Nieuwenhuyse B; Bacteriophage Therapy Providers; Bacteriophage Donors; Soentjens P, Lavigne R, Merabishvili M. Pirnay JP, et al. Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4. Nat Microbiol. 2024. PMID: 38834776 Free PMC article.
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J. Jault P, et al. Among authors: resch g. Lancet Infect Dis. 2019 Jan;19(1):35-45. doi: 10.1016/S1473-3099(18)30482-1. Epub 2018 Oct 3. Lancet Infect Dis. 2019. PMID: 30292481 Free article. Clinical Trial.
[Phage therapy for respiratory infections].
Mitropoulou G, Gijs PJ, Koutsokera A, Sauty A, Blanchon S, Csajka C, Brunet JF, Resch G, Guery B, Von Garnier C. Mitropoulou G, et al. Among authors: resch g. Rev Med Suisse. 2022 Nov 16;18(804):2150-2156. doi: 10.53738/REVMED.2022.18.804.2150. Rev Med Suisse. 2022. PMID: 36382975 French.
From microbiome composition to functional engineering, one step at a time.
Burz SD, Causevic S, Dal Co A, Dmitrijeva M, Engel P, Garrido-Sanz D, Greub G, Hapfelmeier S, Hardt W-D, Hatzimanikatis V, Heiman CM, Herzog MK-M, Hockenberry A, Keel C, Keppler A, Lee S-J, Luneau J, Malfertheiner L, Mitri S, Ngyuen B, Oftadeh O, Pacheco AR, Peaudecerf F, Resch G, Ruscheweyh H-J, Sahin A, Sanders IR, Slack E, Sunagawa S, Tackmann J, Tecon R, Ugolini GS, Vacheron J, van der Meer JR, Vayena E, Vonaesch P, Vorholt JA. Burz SD, et al. Among authors: resch g. Microbiol Mol Biol Rev. 2023 Dec 20;87(4):e0006323. doi: 10.1128/mmbr.00063-23. Epub 2023 Nov 10. Microbiol Mol Biol Rev. 2023. PMID: 37947420 Free PMC article. Review.
Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.
Shlezinger M, Khalifa L, Houri-Haddad Y, Coppenhagen-Glazer S, Resch G, Que YA, Beyth S, Dorfman E, Hazan R, Beyth N. Shlezinger M, et al. Among authors: resch g. Curr Top Med Chem. 2017;17(10):1199-1211. doi: 10.2174/1568026616666160930145649. Curr Top Med Chem. 2017. PMID: 27770768 Review.
136 results